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Abstract: Background:   In comparison to synthetically derived surfactants, biosurfactants
produced from microbial culture are generally regarded by industry as being more
sustainable and possess lower toxicity. One major class of biosurfactants are
rhamnolipids primarily produced by   Pseudomonas aeruginosa.   Due to its
pathogenicity rhamnolipid synthesis by this species is viewed as being commercially
nonviable, as such there is a significant focus to identify alternative producers of
rhamnolipids.
 
Results:   To achieve this, we phenotypically screened marine bacteria for
biosurfactant production resulting in the identification of rhamnolipid biosynthesis in a
species belonging to the   Marinobacter   genus. Preliminary screening showed the
strain to reduce surface tension of cell-free supernatant to 31.0 mNm  -1  . A full-
factorial design was carried out to assess the effects of pH and sea salt concentration
for optimising biosurfactant production. When cultured in optimised media 
Marinobacter   sp. MCTG107b produced 740 ± 28.3 mgL  -1   of biosurfactant after 96
h of growth. Characterisation of this biosurfactant using both HPLC-MS and tandem
MS showed it to be a mixture of different rhamnolipids, with di-rhamnolipid Rha-Rha-C
10  -C  10   being the most predominant congener. The strain exhibited no
pathogenicity when tested using the   Galleria mellonella   infection model. 
 
Conclusions:   This study expands the paradigm of rhamnolipid biosynthesis to a new
genus of bacterium from the marine environment. Rhamnolipids produced from 
Marinobacter   have prospects for industrial application due to their potential to be
synthesised from cheap, renewable feed stocks and significantly reduced pathogenicity
compared to   P. aeruginosa   strains.
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Response to Reviewers: Listed Response To Reviewer’s Comments: MICF-D-19-00270
Reviewer #1: This study reported novelty about the identification of rhamnolipid
biosynthesis in a species belonging to the Marinobacter genus after a phenotypic
screening. The strain Marinobacter sp. MCTG107b exhibited no pathogenicity, proving
to be promising for biosurfactant production. Useful information were obtained by the
authors regarding the influence of salinity and pH in medium composition for
biosurfactant production, extraction, and characterization of the produced
biosurfactant. This paper contains enough new, significant and interesting information
to deserve publication. However, the following issues must be addressed by a minor
revision before its acceptance.
1. Changes in salinity per si can lead to changes in superficial tensions. Did the
authors consider this? A simple test of superficial tension using the medium with the
salinity concentrations used at the FFD could prove that this was not the source of the
observed superficial tension reduction. In this way, the authors ensure that the
superficial tension reduction is due only to biosurfactant production.
Response: We thank the reviewer for positive comments about our manuscript. We
have performed surface tension measurement of Zobell marine media with salinity
concentrations used at FFD. We observed that salinity was not a source of the surface
tension reduction. In our study, there was a marked fall in surface tension during the
exponential growth phase coupled with a sustained low surface tension during
stationary phase which indicated the biosurfactant produced by strain MCTG107b. This
was further supported by gravimetric analysis of biosurfactant yield as well as
quantitative analysis using HPLC-MS.
2. Should the results of reduction in superficial tension agree with the biosurfactant
yield? Why the 3D response surface plots of both dependent responses are not
coincident?
Response: The results of reduction in superficial tension agree with the biosurfactant
yield. The increase in salinity concentration influenced positively, in a statistically
significant way, leading to higher biosurfactant yield (Fig 1A).
However, the 3D response surface plots of both dependent responses are not
coincident. Since the increase in salinity concentration influenced negatively, in a
statistically significant way, the increase in biosurfactant production, leading to lower
surface tension (Fig 1B). We have made appropriate changes in Results section.
3. In the biosurfactant production by Marinobacter sp. MCTG107b in bioreactor, when
assessed gravimetrically, the mean biosurfactant yield obtained by liquid phase
extraction and SPE purification of the cell-free supernatant volume was 740 mgL-1 (±
28.3 mgL-1). However, when Orcinol assays followed by HPLC-MS analysis were
carried out on samples obtained from the bioreactor cultures the concentration of
glycolipids obtained was 150 μgml-1 of culture. What can this difference be attributed
to?
What other compounds may be considered in gravitometry that were not detected as
glycolipids by the Orcinol method? The authors could please include the explanation at
the discussion topic.
Response: Orcinol assay is a colorimetric method for the rapid indication of
rhamnolipid in the fermentation broth. However, the limitation of orcinol method is that
it is not specific for rhamnose and impurities present in the sample might interfere with
the actual yield. Therefore, the method provides an inaccurate estimation of
rhamnolipid concentration when compared to the purified rhamnolipid sample
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measured gravimetrically.
We performed SPE purification of crude biosurfactant to remove unwanted fatty acids
from the sample. SPE removed excess lipids from the sample which gave an absolute
quantification of rhamnolipid yield. We followed the criteria suggested by Irorere et al.
(2017) to quantify biosurfactant yield gravimetrically. The final yield of rhamnolipid was
740 ± 28.3 mgL-1 from the SPE purified sample. We have made appropriate changes
in the Discussion section emphasising that.
Reviewer #2: The work by Tripati et al (MICF-D-19-00270) describes the isolation of a
Marinobacter sp strain (MCTG107b) that produces rhamnolipids (RL) after the initial
characterization of five Marinobacter isolates. The authors follow an optimization
strategy to determine the pH (6.5) and salt concentration (30 g/L) conditions for RL
production and characterized the congeners that this strain produces in this culture
medium. This strain produces mainly di-RL (95%) and the most abundant congener is
Rha-Rha-C10-C10 (52%).
I consider that this article is suitable for its publication in Microbial Cell Factories, but I
suggest the following modifications before it is accepted for publication.
1. The authors report that Marinobacter MCTG107b produces 750 mg/L (measured
gravimetrically) when cultured in a 5 L bioreactor using the optimized medium. It would
be interesting that the authors provide for comparison, the yield of a P. aeruginosa
strain under optimal conditions.
Response: We have added the information regarding the yield of P. aeruginosa in the
Discussion section as suggested.
2. The authors test Marinobacter MCTG107b virulence in the Galleria mellonella model
(which has been shown to posses an innate immune response and to yield similar
results to the murine model), using Pseudomonas aeruginosa PAO1 strain as a
positive control. In the Materials and Methods section the authors state that they use a
bacterial suspension of a 1,000 CFU, which is within the range of the number of CFU
that are used to test virulence, but in the description of the results presented in Fig. 4,
(page 16 lines 396-397), they say that they use a similar inoculum as that used for
PAO1 strain (around 20 CFU). If this is just a writing mistake it should be corrected,
since non-pathogenic bacteria have been shown to be harmless at concentrations as
high as 100,000 CFU per larvae (https://doi.org/10.3389/fmicb.2019.00311,
https://doi.org/10.3389/fmicb.2019.01791). However, if Marinobacter MCTG107b was
really injected at a low dose the experiment should be done again using at least 1,000
CFU.
Response: We thank the reviewer for pointing this out and as he/ she stated, this is a
writing mistake. Based on a correlation of viable count and OD throughout the growth
cycles, bacterial cultures (both 107b and PAO1) were diluted to a concentration of 5 X
104 CFU/ml, therefore providing a dose of 1000 CFU per 20 µL inoculum. This mistake
has been corrected in both the Material and Methods and the Results sections of the
revised manuscript. We also carried out experiments inoculating larvae with
significantly higher doses of 107b, (up to 10,000 CFU), and observed the same level of
survival. This point has been added to the Results section of the revised manuscript.
However, as these experiments were carried out in the absence of a PAO1 group due
to the fact that such a high dosage of P. aeruginosa would induce 100% mortality in the
larva after a very short incubation period we did not include the data.
3. In the Discussion section the authors say that they were not able to detect rhlA, rhlB
and rhlC genes using primers designed to amplify P. aeruginosa and Burkholderia
genes, so they conclude that Marinobacter MCTG107b use enzymes with diverse
sequences from known RhlA, RhlB and RhlC to synthetize RL. However the lack of
PCR amplification of rhl gene homologs might be due to small differences in the
sequence of the region of the primers used and not to the presence of genes coding
for enzymes with "significantly different peptide sequences" in Marinobacter
MCTG107b. Therefore, I consider that the lack of PCR amplification cannot be used as
an argument to sustain the existence of non-homologous genes in Marinobacter
MCTG107b.
Response: Since the drafting of this manuscript we have continued our investigations
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
into the presence of the RL biosynthesis genes within 107b. To do this we took the
approach of designing multiple degenerate primers based on sequence alignments of
published rhlA-C genes in both the Pseudomonas and Burkholderia genera. As yet we
have been unable to amplify any fragment of DNA that has the potential to be an
orthologue of these gene in 107b. Therefore, we stand by our conclusion that the
biosynthesis of RL by this strain is being carried out by enzymes with significantly
different sequences to that already known in both Pseudomonas and Burkholderia
strains. Our work in this area is ongoing and is now aided by the possession of the
complete 107b genome which, as we state in the manuscript, we are analysing
bioinformatically. We hope to make the elucidation of the RL biosynthesis pathway
within this strain the subject of a future publication. For now, we have amended the
Discussion section of the revised manuscript to clarify our current findings and ongoing
work around this issue.
4. In addition the authors argue that the production of Rha-C10 support their
conclusion of a diverse RL biosynthesis pathway in Marinobacter MCTG107b, but RL
containing only one fatty-acid moiety have been reported in P. aeruginosa cultures
after long incubation periods and are much likely a product of degradation, which might
be the case also with MCTG107b strain.
Response: We recognise that RL congeners possessing one fatty acid moiety have
been reported in P. aeruginosa and that their presence may be due to degradation of
congeners possessing the more common structure of two fatty acid moieties following
a prolonged incubation period. However, our analysis of the congeners synthesised by
107b was not after a prolonged incubation period. Additionally, the percentage relative
abundance of the Rha-Rha-C10 congener was at a level (5.13%) significantly higher
than previously observed in P. aeruginosa. Finally, we also identified a product with a
structure of Rha-Rha-C8 accounting for a relative abundance of 1.95%, however no
congener with a structure of Rha-Rha-C8-C8 was observed. Taking these three points
together we would rule out degradation as an explanation of the presence of these
congeners with singular fatty acids and therefore stand by our initial conclusion.
5. In addition the authors sustain the involvement of horizontal gene transfer (HGT) of
rhl genes into Marinobacter MCTG107b, based on the lack of detection of these genes
by PCR, but I consider that the fact that this particular strain is unique in its ability to
produce RL as compared with other Marinobacter isolates (Table 1) is sufficient
evidence to support the involvement of HGT in Marinobacter MCTG107b ability to
produce RL. The involvement of HGT in rhl genes inheritance by only some strains of a
bacterial species has been discussed previously (Toribio et al., 2010).
The strategy of analyzing Marinobacter MCTG107b whole genome sequence to detect
genes involved in RL biosynthesis is a straight forward approach, but I consider that
the sequencing of other Marinobacter strains might not give information about the
genes involved in the biosynthesis of this biosurfactant in Marinobacter, precisely
because these genes seems to be inherited by HGT.
In summary, I consider that the Discussion section needs to be modified taking into
account these points.
Response: We thank the reviewer for this very interesting assessment of the potential
for HGT, however we do make this point using the reference Toribio et al., 2010 in the
discussion section of the manuscript. In light of the reviewers comment we have
modified our Discussion section with aim of making this point clearer. With regards to
the WGS analysis pathway we are currently using, a point that is also mention in the
Discussion section on the manuscript. Our plan is to compare the newly acquired
genome of MCTG107b with the published genome sequences of other similar non-RL
synthesising Marinobacter strains to detect regions of the genome that are either
unique or significantly different and therefore might be due to HGT accounting for RL
synthesis in this strain. We anticipate this work will form the basis of a future
publication; therefore, we do not wish to elaborate further in this current manuscript.
Reviewer #3: Overall, the methodology in this study is well established and manuscript
is carefully prepared.
There are still a few minor points to be addressed to improve the manuscript.
1. The writing of degrees Celsius (°C) should be corrected in the entire manuscript. It
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(°C) should be written separated from the previous number and correct sign should be
used.
Response: Revised as suggested.
2. The abbreviation for "liters" must be the same (l or L) throughout the manuscript. For
example; in Line 169 it is written as ml; in Line 179 it is written as mL.
Response: Revised, ml changed to mL.
3. In line 54 and 166: The references should be corrected
Response: Corrected as suggested.
4. In Lines 193-201: No need to repeat the company name of rapeseed oil (Sigma-
Aldrich) in all mention.
Response: Revised as suggested
5. Line 261: Please correct the sentence as … At each time point, individual larva
"was" recorded as either live or dead ….
Response: Changed from were to was
6. Line 271: Please correct the sentence as …. accession numbers "shown" in Table
1….
Response: Made appropriate changes in Materials and Methods section.
7. Please mention why only 2 parameters (sea salt concentration and pH) for
enhancement of biosurfactant production are selected when more parameters could be
worked on simultaneously.
Response: Several studies have reported that salinity and pH have major influence on
the bacterial growth and biosurfactant production. The subtle changes in salinity and
pH can exert an important effect on microbial communities in the marine environment.
Therefore, we worked on these two important parameters for biosurfactant optimisation
in marine isolate MCTG107b. Our FFD design showed biosurfactant production was
increased at a pH 5.5-6.8 and sea salt concentration 22.5-45 gL-1 which indicated that
the selected parameters have a significant effect on the biosurfactant production.
We elected to further focus our study on the identification of the biosurfactant
compound produced by novel marine isolate. We performed the characterisation of the
rhamnolipid using HPLC-MS and Tandem-MS. Also, tested the non-virulence of the
isolate in Galleria wax worm model.
Additional Information:
Question Response
<b>Is this study a clinical
trial?</b><hr><i>A clinical trial is defined
by the World Health Organisation as 'any
research study that prospectively assigns
human participants or groups of humans
to one or more health-related
interventions to evaluate the effects on
health outcomes'.</i>
No
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Abstract 16 
Background: In comparison to synthetically derived surfactants, biosurfactants 17 
produced from microbial culture are generally regarded by industry as being more 18 
sustainable and possess lower toxicity. One major class of biosurfactants are 19 
rhamnolipids primarily produced by Pseudomonas aeruginosa. Due to its 20 
pathogenicity rhamnolipid synthesis by this species is viewed as being commercially 21 
nonviable, as such there is a significant focus to identify alternative producers of 22 
rhamnolipids. 23 
Results: To achieve this, we phenotypically screened marine bacteria for 24 
biosurfactant production resulting in the identification of rhamnolipid biosynthesis in a 25 
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species belonging to the Marinobacter genus. Preliminary screening showed the 26 
strain to reduce surface tension of cell-free supernatant to 31.0 mNm-1. A full-27 
factorial design was carried out to assess the effects of pH and sea salt 28 
concentration for optimising biosurfactant production. When cultured in optimised 29 
media Marinobacter sp. MCTG107b produced 740 ± 28.3 mgL-1 of biosurfactant after 30 
96 h of growth. Characterisation of this biosurfactant using both HPLC-MS and 31 
tandem MS showed it to be a mixture of different rhamnolipids, with di-rhamnolipid, 32 
Rha-Rha-C10-C10 being the most predominant congener. The strain exhibited no 33 
pathogenicity when tested using the Galleria mellonella infection model.  34 
Conclusions: This study expands the paradigm of rhamnolipid biosynthesis to a 35 
new genus of bacterium from the marine environment. Rhamnolipids produced from 36 
Marinobacter have prospects for industrial application due to their potential to be 37 
synthesised from cheap, renewable feed stocks and significantly reduced 38 
pathogenicity compared to P. aeruginosa strains. 39 
 40 
Key Words  41 
Biosurfactant; Glycolipid; HPLC-MS; Marine bacteria; Marinobacter; Rhamnolipid 42 
 43 
Background 44 
Surfactant compounds possess both hydrophobic and hydrophilic moieties: they can 45 
modulate surface and interfacial tensions and are therefore widely utilised in a 46 
variety of different industries. Though many of these surfactant compounds are 47 
derived synthetically from petrochemical sources, numerous microorganisms have 48 
been shown to synthesise surfactant compounds. Surfactant compounds produced 49 
from a biological source are termed biosurfactants and are generally viewed as 50 
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3 
being more sustainable and less toxic than their synthetically derived alternatives [1]. 51 
Marine microorganisms have been shown to be able to produce biosurfactants under 52 
extreme environments, caused by changes in salinity, increased UV exposure, 53 
limited nutrients, fluctuations in temperatures and pH [2-4)]. Many marine bacterial 54 
species, commonly from oil-contaminated waters, have been reported to produce 55 
biosurfactants, and include members belonging to the genera Alcanivorax, 56 
Alteromonas, Pseudoalteromonas and Halomonas [5-7]. The biosurfactants they 57 
produce have the ability to solubilise hydrocarbons from the surrounding 58 
environment, which enhances the growth of indigenous bacteria capable of 59 
degrading aliphatic and polycyclic aromatic hydrocarbons (PAHs) [8]. These species 60 
therefore have tremendous industrial potential especially for application in microbial 61 
enhanced oil recovery (MEOR) and bioremediation purposes [7, 9, 10]. Furthermore, 62 
biosurfactant produced by psychrophilic marine bacteria are potentially exploitable in 63 
industrial processes for the preparation of biological detergents that are active at 64 
lower temperatures [11]. 65 
Particularly in the oligotrophic conditions of open ocean environments, marine 66 
bacteria have evolved to compete for the limited resources available to them. With 67 
respect to biosurfactants, they may be produced as secondary metabolites as, for 68 
example, to access hydrophobic growth substrates or to directly attack rival bacterial 69 
species competing for limited growth and energy sources [12]. In the latter case, 70 
biosurfactant compounds could be considered applicable for combatting pathogenic 71 
antibiotic-resistant microorganisms [13, 14]. Biosurfactants have also been shown to 72 
play an important role in biofilm development, the maintenance of biofilm structure 73 
and in substrate adhesion [15]. Abrogating the bacterium’s ability to produce a 74 
biosurfactant could therefore disrupt biofilm growth with a multitude of potential 75 
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4 
applications including reducing infection risk to patients receiving implantable 76 
medical devices such as catheters [16, 17]. 77 
Biosurfactant compounds possess a wide array of molecular structures and 78 
are often classified based on their structure. One of the best studied groups of 79 
biosurfactants are the glycolipids, specifically rhamnolipids [10]. Rhamnolipids are 80 
composed of one or two rhamnose units linked in a 1, 2-glycosidic linkage to two β-81 
hydroxy fatty acids (β-OH-FA or 3-OH-FA) ranging between 8-18 carbons in length. 82 
The most studied rhamnolipids are those produced by the Gram negative, 83 
opportunistic pathogen Pseudomonas aeruginosa [18]. Rhamnolipids have a broad 84 
range of potential applications in various industries, including for MEOR in the 85 
petroleum industry, as emulsifiers in the food and cosmetic industries, and as anti-86 
microbial/ therapeutically-active agents in the pharmaceutical industry [19]. Despite 87 
their versatile potential industrial applications, the exploitation of rhamnolipids has 88 
been limited due to the pathogenic nature of P. aeruginosa. To overcome this there 89 
has been an increased interest in the discovery of non-pathogenic rhamnolipid 90 
producers. Recent reports have shown rhamnolipid production by non-pathogenic 91 
species of Pseudomonas. For example, a non-pathogenic rhamnolipid-producing 92 
marine Pseudomonas sp. MCTG214(3b1) was shown to produce both mono and di-93 
rhamnolipids [20]. An arctic marine bacterium identified as Pseudomonas 94 
fluorescence species was reported to synthesise five mono-rhamnolipid congeners 95 
[21]. Outside of the Pseudomonas genus, rhamnolipids have been shown to be 96 
synthesised by a number of non-pathogenic species of the genus Burkholderia [22, 97 
23]. Discovery and isolation of novel non-pathogenic rhamnolipid producers is an 98 
attractive route to compete with the synthetic surfactants and meet future global 99 
biosurfactant requirements. Global estimates of microbial cell abundances in 100 
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5 
seawater range from 104 to 107 cells per millilitre, with an estimated average 101 
taxonomic diversity of 1000 species per millilitre [24]. Collectively, this offers a 102 
significant opportunity to discover novel biosurfactant producers, including that 103 
produce rhamnolipids, and that are non-pathogenic [25]. Importantly for commercial 104 
exploitation, it is essential that the economics underlying the production of the 105 
biosurfactants is viable and able to compete with chemically-derived surfactants in 106 
the global market. This needs to be achieved by reducing manufacturing costs and 107 
enhancing fermentation yields. There are numerous factors for optimising the 108 
process of biosurfactant production, including optimising the composition of the 109 
culture medium, pH, dissolved oxygen levels during growth, culture agitation and 110 
incubation temperature. Statistical design of experiments (DoE) methods, such as 111 
full factorial design (FFD), have been shown to be an efficient and useful method to 112 
optimise biosurfactant production using a reduced number of experiments [26-28]. 113 
In this study, we investigated biosurfactant production in five bacterial strains 114 
isolated from coastal and offshore sites in the USA, Scotland and Norway, and all 115 
phylogenetically identified to belong to the genus Marinobacter. One of these strains, 116 
Marinobacter sp. MCTG107b, possessed phenotypic traits indicative of biosurfactant 117 
synthesis. The bioprocess factors for biosurfactant production in this strain were 118 
optimised for maximum production yield in shake-flask culture using FFD. Using high 119 
performance liquid chromatography-mass spectrometry (HPLC-MS) and tandem-120 
MS, the chemical structure of the biosurfactants produced by this strain were 121 
analysed and confirmed to be rhamnolipids. This study reports the first description of 122 
rhamnolipid production by a Marinobacter and, importantly also, extends the 123 
paradigm of rhamnolipid production to a new bacterial genus which is recognised as 124 
ubiquitous in the marine environment and commonly associated with oil spills. 125 
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 126 
Materials and Methods 127 
Strains and culture conditions 128 
The marine bacteria used in this study were isolated from surface seawater samples 129 
collected from offshore location in the USA, UK and Norway (Table 1). The method 130 
of isolation has been previously described by Twigg et al [20]. Following isolation, 131 
these strains were routinely cultured at 30 °C oC in ZM/1 medium which consists of 132 
30 gL-1 sea salts (Sigma-Aldrich), 5 gL-1 Bacto Peptone (BD Biosciences), 1 gL-1 133 
yeast extract (Sigma-Aldrich) and supplemented with trace elements and vitamins 134 
after autoclaving [29]. P. aeruginosa strain PAO1 was purchased from the ATCC 135 
(ATCC 15692) and was cultured at 37 °C oC in Nutrient Broth (Oxoid). Solid media 136 
plates used in this study were composed of appropriate culture media supplemented 137 
with 1.5% (w/v) agar (Sigma-Aldrich). 138 
 139 
Phylogenetic identification 140 
Genomic DNA (gDNA) was extracted from approx. 1×108 bacterial cells via a 141 
DNeasy Blood and Tissue Kit (Qiagen) used as per the manufactures instructions for 142 
Gram-negative bacteria. Extracted gDNA was quantified and assessed for purity by 143 
measuring absorbance at 260 nm and 280 nm using a Nanodrop 2000 144 
spectrophotometer (Thermo Fischer). The 16S rRNA gene was then ampliﬁed using 145 
the Polymerase Chain Reaction (PCR) with the universal primers 9bfm and 1512uR. 146 
PCR reactions contained 50 ng of gDNA, 1.5 mM MgCl2, 1 × PCR buffer (Thermo 147 
Fischer), 0.2 mM dNTP mix (Thermo Fischer), 0.5 mM of each primer (Thermo 148 
Fischer), and 2 U of Taq DNA polymerase (Thermo Fischer). The PCR reaction was 149 
as follows: one cycle initial denaturation at 94 °C for 3 min; 30 cycles of denaturation 150 
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at 94 °C for 45 sec; annealing step at 52 °C for 30 sec; extension step at 72 °C for 151 
90 sec; and one cycle final extension at 72 °C for 5 min. Following ampliﬁcation, 152 
PCR products were separated on a 1% (w/v) agarose gel made with TBE buffer 153 
(Thermo Fischer), and amplicons of approx. 1.5 kb were subsequently puriﬁed from 154 
the gel using a Wizard SV Gel and PCR Clean Up System (Promega). Amplified 16S 155 
rDNA was quantified and assessed for purity as above. The purified 16S rDNA was 156 
sequenced using the Sanger method by Eurofins Genomics (Cologne, Germany) 157 
with primers 9bfm, 536F, 907R and 1512uR [30, 31]. The resultant DNA sequences 158 
were compared to the NCBI nucleotide database using BLASTn. 159 
 160 
Phenotypic screening for biosurfactant production 161 
The five marine bacterial strains were screened for their ability to reduce surface 162 
tension and to emulsify oil in water. Bacterial cultures were centrifuged at 13,000×g 163 
for 15 min and the supernatant fractions (in triplicate) used to perform surface 164 
tension measurements at room temperature (21 °CoC) according to the Du Noüy ring 165 
method using a K10ST A KRÜSS KIOT Tensiometer (Krϋss) .[32]. The surface 166 
tension of sterile ZM/1 media supplemented with 1% (v/v) rapeseed oil (Sigma-167 
Aldrich) was also measured as a comparative control. To evaluate for emulsification, 168 
the emulsification index (EI) of the supernatant fractions was measured by adding 2 169 
mLl of the supernatant to an equal volume of kerosene and vortexing at high speed 170 
for 2 min. The stability of resultant emulsions was observed after 24 h settlement. 171 
The EI24 (i.e. EI after 24 hours) was calculated as a percentage of the height of the 172 
emulsified layer to the total height of the liquid prior to emulsification by vortexing 173 
[33]. As a control for comparison, sterile ZM/1 medium was used. 174 
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Optimization of growth conditions 176 
The growth of MCTG107b in different physical and media conditions was 177 
investigated. For this, shake flask experiments were carried out in 1 L Erlenmeyer 178 
flasks containing 90 mL of ZM/1 medium and inoculated (10% v/v) with a seed 179 
culture grown under the standard conditions described earlier. For the carbon 180 
source, glucose 1% (w/v) final concentration was used in all experiments. All flasks 181 
were incubated in a rotary orbital incubator set at 200 rpm. However, physical and 182 
media conditions tested included various concentrations of sea salts (5, 10, 20, 30 183 
and 40 gL-1), temperature (25, 28, 30 and 37 °CoC) and pH (4.0, 5.5, 7, 8.5). 184 
Samples of the culture medium in these various experiments were taken at various 185 
time points for optical density (OD) measurements at 600 nm to monitor the growth 186 
of the cells. 187 
 188 
Optimisation of growth media for biosurfactant production 189 
The effect of sea salt concentration and pH for enhancement of biosurfactant 190 
production by MCTG107b was carried out by FFD, using surface tension, (measured 191 
as described previously), and biosurfactant yield, (measured gravimetrically), as 192 
response variables. These experiments were carried in shake flask culture using 193 
ZM/1 medium supplemented with 1% (v/v) rapeseed oil (Sigma-Aldrich) with various 194 
concentrations of sea salts (5 to 40 gL-1) and pH (5.5 to 8.5) according to the 195 
experimental designs (Supplementary Table 1). In total, 14 experiments were 196 
performed (22 FFD with 8 assays and 6 replicates at the centre point). 197 
 198 
Biosurfactant extraction and purification 199 
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Biosurfactant compounds were extracted and purified from 3-L cultures of strain 200 
MCTG107b when grown in optimised ZM/1 medium supplemented with 1% (v/v) 201 
rapeseed oil (Sigma-Aldrich) using a 5.0 L Biostat B bioreactor (Sartorius Stedim) 202 
equipped with a mechanical foam separator. The reactor vessel was inoculated 203 
(10% v/v) with a MCTG107b seed culture grown to exponential phase in ZM/1 204 
supplemented with 1% (w/v) glucose at 30 °C and 200 rpm. Internal temperature of 205 
the culture was maintained at 30 °CoC throughout the growth cycle. Stirrer speed 206 
and aeration varied between 300 and 600 rpm in order to maintain DO2 levels at 207 
50%. Cultures were incubated for 96 h; during growth, dissolved oxygen and pH 208 
were continually monitored and samples were taken at 24 h intervals to monitor 209 
growth and BS. 210 
 211 
At the termination of the culture (96 h), the biosurfactants were extracted using liquid 212 
phase extraction. For this, the culture volume was first centrifuged (13,000×g; 213 
15 min) and then the supernatant collected and acidified to pH 2.0 with 1M HCl 214 
(Sigma-Aldrich) prior to extraction three times with an equal volume of ethyl acetate 215 
(Sigma-Aldrich). The organic phase was separated and dried using MgSO4 (Sigma-216 
Aldrich), filtered and rotary evaporated under vacuum at 40 °C to obtain a crude 217 
extract [34]. Crude extracts were then purified by Solid Phase Extraction (SPE) using 218 
Strata SI-1 Silica (55 μm, 70 Å) Giga tubes (Phenomenex). Purified BS extracts were 219 
gravimetrically assessed and stored at 4 °C for further analysis [35]. 220 
 221 
Chemical analysis of biosurfactant compounds 222 
Biosurfactant compounds extracted from strain MCTG107b were initially analysed 223 
using the orcinol method [34]. To each 100 μL sample, 900 μL of a solution 224 
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10 
containing 0.19 % (w/v) orcinol (Sigma-Aldrich) in 53 % H2SO4 (Sigma-Aldrich) was 225 
added. Samples were then heated to 80 °C for 30 min, after which the samples were 226 
cooled to room temperature. The absorbance of the samples was measured at 227 
421 nm. The concentration of glycolipid present in the samples were calculated to 228 
those generated using a standard rhamnose at concentrations of 0-100 μgmL-1 [36]. 229 
 230 
Individual biosurfactant congeners were identified in the SPE purified extract by a 231 
UHPLC system with RS Diode Array detector (ThermoFisher Scientific) in 232 
conjunction with the amaZon SL dual funnel Ion Trap spectrometer LCMS system 233 
(Bruker). An analytical column of Acclaim RSLC, 120 C18, 2.2 μm 120Å (2.1 x 100 234 
mm) (ThermoFisher Scientific) was used for analysis. The gradient elution sequence 235 
used was as follows: 20% B to 100% in 30 min, 100% B for 10 min, 20% B in 5 min. 236 
Solvents A= H2O (0.1% TFA), B=AcCN (0.1%TFA). The sample injection volume 237 
used was 10 μL. Spectra were acquired in the positive mode from m/z 200 to 2000. 238 
Tandem-MS was performed using Thermos System LC P4000 (ThermoFisher 239 
Scientific) coupled to a LCQ classic MATT ion trap mass spectrometer 240 
(ThermoFisher Scientific) equipped with a 150 Χ 4.6 mm Kinetex 5 µM F5 100 Å LC 241 
column. HPLC-grade water and analytical-grade acetonitrile were used as mobile 242 
phase. The sample injection volume was 5 µl µL and the spectra were acquired in 243 
the negative mode from m/z 175 to 700. The fragmentation of the molecules was 244 
done with helium gas at the normalised 40% collision energy with the activation q 245 
value of 0.25. 246 
 247 
Galleria mellonella infection model 248 
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Virulence assessment of strain MCTG107b was carried out using the G. mellonella 249 
infection model (Hill et al. 2014). A comparative positive control for these 250 
experiments was P. aeruginosa PAO1 (ATCC 15692). Using the Miles and Misra 251 
method [37], viable count (CFU) and OD 600 nm were correlated throughout the 252 
growth cycles of both strains. Following this, 10 mL Ten millilitres of stationary phase 253 
culture was centrifuged (10,000×g; 20 min) and the pelleted cells washed in sterile 254 
phosphate buffered saline (PBS). The washed cells were re-suspended to OD 600 255 
nm 0.4 in PBS to a concentration of 5×104 CFUmL-1. Using the Miles and Misra 256 
method [37], the CFU count at OD 600 nm of 0.4 was established and the samples 257 
diluted in sterile PBS to a concentration of 1×103 CFUml-1. G. mellonella larvae (Pets 258 
at Home, Belfast) of approx. 20 mm in length and 200 mg in weight were selected 259 
and 20 μl μL of either bacterial sample (1000 CFU) or PBS (negative control) was 260 
injected into the posterior pro-leg of individual larvae (n=10 per experimental group). 261 
Injection was carried out using a 0.30 mm (30G) x 8 mm hypodermic needle (BD). 262 
Immediately following injection, the larvae were incubated at 37 °C and observed at 263 
set time points during the course of a 48 h period. At each time point, individual larva 264 
were was recorded as either live or dead. The experiment was performed on three 265 
independent occasions which gives a total of n=30 per experimental group [20, 38]. 266 
 267 
Statistical analysis and data availability 268 
Statistical analysis of bacterial growth experiments was carried out in GraphPad 269 
Prism V.7 using a one-way ANOVA followed by Tukey’s post-hoc testing; the 270 
significance of the results was tested at p < 0.05 level. The data obtained from FFD 271 
experiments were subjected to statistical analysis by TIBCO Statistica software 272 
version; the significance of the results was tested at p < 0.05 level. All sequence data 273 
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12 
was submitted to GenBank (NCBI, USA) and the assigned accession numbers of 274 
strains are given shown in Table 1. 275 
 276 
Results 277 
Strain identification and initial phenotypic screening 278 
Five marine bacterial isolates – MCTG107b, MCTG4b, MCTG106, MCTG167 and 279 
MCTG161(2c3) – were investigated for biosurfactant production. BLASTn analysis of 280 
partial 16S rRNA gene sequences from these strains showed >99% similarity to the 281 
genus Marinobacter (Table 1). Following phenotypic screening, strains which 282 
reduced the surface tension of culture medium to below 35 mNm-1 and/or produced 283 
a stable emulsion after 24 h were considered as potential biosurfactant(s) producers 284 
(Table 1). Strain MCTG167 was unable to form a stable emulsion or to significantly 285 
reduce the surface tension when compared to un-inoculated medium controls (58 286 
mNm-1). Strain MCTG106 and MCTG161(2c3) also showed no significant reduction 287 
in surface tension, however both strains were able to form stable emulsions after 24 288 
h. Strain MCTG4b emulsified kerosene with an EI24 of 40%, whereas it reduced the 289 
ST of supernatant fractions to 38.5 mNm-1. Strain MCTG107b showed the highest 290 
surface activity, significantly reducing the surface tension of the culture broth to 31 291 
mNm-1, and producing stable emulsions with kerosene (EI24 of 40%). Therefore, 292 
Marinobacter sp. MCTG107b was selected for further study. 293 
 294 
Bacterial growth of Marinobacter sp. MCTG107b 295 
To determine optimal conditions for the growth of Marinobacter sp. MCTG107b, and 296 
with a view to optimising its production of biosurfactant, growth was monitored in 297 
different physical and media conditions that included evaluating different salinities, 298 
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13 
pH, temperatures and nitrogen sources. Marinobacter sp. MCTG107b grew optimally 299 
at a range of salinity concentrations, from 5.0 gL-1 to 40 gL-1 sea salts. In medium 300 
containing no added sea salts, no growth was observed. Strain MCTG107b grew 301 
optimally within a pH range of 5.5 to 8.5, whereas it was significantly inhibited under 302 
more acidic conditions (pH 4.0). The strain grew optimally at temperatures ranging 303 
from 25 °C to 37 °C (Fig S1). 304 
 305 
Optimization of culture conditions for biosurfactant production 306 
To optimise the media composition for maximal biosurfactant production by strain 307 
MCTG107b, the effects of salinity and pH, as well as the interaction between these 308 
variables was assessed by applying FFD, 22. Compared to pH, salinity was observed 309 
to be the most important factor affecting the reduction of surface tension when this 310 
was measured for cell-free culture supernatant fractions. The surface tension was 311 
found to vary between 30.5 mNm-1 to 40.2 mNm-1 (Table S1). Experimental results 312 
were used to generate two equations that modelled the relation between pH/ salinity 313 
and the outputs biosurfactant yield and surface tension. According to the response 314 
values obtained from the designed experiments, the following regression equations 315 
were obtained for both biosurfactant yield [1] and surface tension [2]: 316 
 317 
𝑌𝑖𝑒𝑙𝑑 = 22.17262 + 39.88095 ∗ 𝑝𝐻(1) + 36.60714 ∗ 𝑆𝑎𝑙𝑡𝑠(2) − 4.64286 ∗ 𝑝𝐻 ∗318 
𝑆𝑎𝑙𝑡𝑠(1 𝑏𝑦 2) [1] 319 
𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝑇𝑒𝑛𝑠𝑖𝑜𝑛 = 50,03036 − 1,70714 ∗ 𝑝𝐻(1) − 0,55690 ∗ 𝑆𝑎𝑙𝑡𝑠(2) + 0,05476 ∗320 
𝑝𝐻 ∗ 𝑆𝑎𝑙𝑡𝑠(1 𝑏𝑦 2) [2] 321 
 322 
Significance of the present model was validated through analysis of variance (p ≤ 0.05) 323 
(Table S2). The observed values for biosurfactant yield were significantly close to 324 
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14 
those determined by the model (R2 = 0.996). The observed and the predicted values 325 
for surface tension modelled here also demonstrated that the experimentally observed 326 
values were significant to those determined by the model (R2 = 0.958). Results from 327 
the FFD analysis for the outputs of biosurfactant yield and surface tension were 328 
expressed as 3D response surface plots showing the relationship between 329 
independent and dependent variables (Fig 1). Increased salinity significantly and 330 
positively influenced biosurfactant yield. Our model demonstrated a significant 331 
relationship between biosurfactant yield and the two variables tested (salinity and pH). 332 
We modelled an increased biosurfactant yield when pH was low and salinity was 333 
increased from the central to the highest level. (Fig 1A). The increase in salinity 334 
positively influenced biosurfactant yield, in a statistically significant way (Fig 1A). 335 
Similarly, tThe model also showed that an increase changes in pH did not cause major 336 
impacts on surface tension, whereas an increase in salinity from the central to highest 337 
point led to a decrease in surface tension. The results of reduction in superficial tension 338 
agree with the biosurfactant yield. However, the 3D response surface plots of both 339 
dependent responses are not a coincident. (Fig 1B). Since, the increase in salinity 340 
concentration negatively influenced, in a statistically significant way, the increase in 341 
biosurfactant production, leading to lower surface tension (Fig 1B). These data 342 
demonstrate salinity and pH are critical factors that markedly affected the production 343 
yield of biosurfactant. Our model showed maximum production of biosurfactant at a 344 
pH 5.0–6.8 and salinity 22.5–40.0 gL-1, resulting in a predicted yield of between 460–345 
800 mgL-1. The optimised medium with a sea salt concentration of 30 gL-1 and pH 6.5 346 
was therefore chosen for all subsequent experiments with strain MCTG107b. 347 
 348 
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15 
Growth and biosurfactant production by Marinobacter sp. MCTG107b in a 349 
bioreactor 350 
Based on our results above, an optimised culture medium was used to produce 351 
biosurfactant from Marinobacter sp. MCTG107b employing a bench-scale 5.0 L 352 
bioreactor. Biomass, culture pH and surface tension were monitored continually 353 
throughout the growth cycle. The cell concentration at the time of inoculation (t = 0 h) 354 
was 2.02×106 CFUml-1. An exponential growth phase was maintained for the first 24 355 
h, followed by a stationary phase from 24 h to 96 h, and the cell concentration 356 
reaching 6.46×109 CFUml-1 by the end of the fermentation (Fig 2). The pH of the 357 
culture was observed to fall during the course of the exponential growth phase and 358 
then remained moderately constant during the stationary phase. A similar pattern 359 
was observed for the surface tension that was measured for cell-free supernatant 360 
samples over the course of the growth phase. The strain achieved the lowest surface 361 
tension value (31 ± 0.7 mNm-1) after 24 h of fermentation and then remained almost 362 
constant until the end of the fermentation (Fig 2). When assessed gravimetrically, the 363 
mean biosurfactant yield obtained by liquid phase extraction and SPE purification of 364 
the cell-free supernatant volume from replicate 96 h bioreactor cultures of 365 
Marinobacter sp. MCTG107b was 740 mgL-1 (± 28.3 mgL-1). 366 
 367 
Chemical characterisation of the biosurfactant produced by Marinobacter sp. 368 
MCTG107b 369 
The traits measured for biosurfactant production (i.e. surface tension reduction and 370 
emulsification) were indicative that Marinobacter sp. MCTG107b produces a 371 
glycolipid biosurfactant. To confirm this, Orcinol assays followed by HPLC-MS 372 
analysis were carried out on samples obtained from the bioreactor cultures.  Orcinol 373 
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16 
assays performed with cell-free supernatant samples indicated the presence of 374 
glycolipids at 150 µgmLl-1 of culture. The production and presence of glycolipids was 375 
further investigated by mass spectrometric analysis. The identification of glycolipid 376 
congeners produced by strain MCTG107b was characterized by HPLC-MS operating 377 
in the positive mode. The observed products possessed m/z values that 378 
corresponded to values for known rhamnolipids, indicating that the biosurfactant 379 
synthesised by strain MCTG107b was a mixture of rhamnolipid congeners. We 380 
identified a variety of separate rhamnolipid congeners present in purified cell-free 381 
supernatant extracts from culture samples of the strain (Table 2). These congeners 382 
included both mono- and di-rhamnolipids; however, there was an overwhelming 383 
preference toward the synthesis of di-rhamnolipid (95.39% of total rhamnolipid 384 
abundance). The congener with the highest relative abundance (52.45%) possessed 385 
an m/z value of 651.73. This value correlated with α-L-rhamnopyranosyl-α-L-386 
rhamnopyranosyl-β-hydroxydecanoyl-β-hydroxydecanoate (Rha-Rha-C10-C10) with a 387 
molecular weight of 650.79 Da. The next most abundantly synthesised congeners 388 
were Rha-Rha-C10-C10CH3 (23.07%), Rha-Rha-C10 (5.13%), Rha-Rha-C10-C12 389 
(5.01%), Rha-Rha-C10-C12CH3 (3.26%) and Rha-C14:2 (3.18%) (Table 2). As 390 
rhamnolipid production has not been previously observed in any member of the 391 
Marinobacter genus, these data were further investigated for confirmatory evidence 392 
of this. For this, tandem-MS was performed on the major molecular ion shown to be 393 
synthesised by strain MCTG107b. Tandem-MS analysis of the compound with an 394 
m/z of 651.73 revealed the detection of ‘daughter’ ions with molecular weights 395 
indicative of the fragmentation of Rha-Rha-C10-C10 (Fig 3). These data, together with 396 
the phenotypic results and initial HPLC-MS and Nuclear Magnetic Resonance (NMR) 397 
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17 
spectroscopy analysis (data not shown), confirms the synthesis of rhamnolipid by 398 
Marinobacter sp. MCTG107b. 399 
 400 
Assessment of virulence using the Galleria mellonella infection model 401 
The potential virulence of Marinobacter sp. MCTG107b was assessed and compared 402 
to that of the rhamnolipid producing opportunistic pathogen P. aeruginosa using the 403 
G. mellonella infection model. P. aeruginosa PAO1 killed 100% of the infected larvae 404 
24 h post inoculation with as little as 20 1000 CFU. When larvae were inoculated with 405 
an equal CFU count of Marinobacter sp. MCTG107b or with sterile PBS, the larvae 406 
showed 97% survival 48 h post inoculation, with only one larva dying in each 407 
experimental group at 22 and 20 hours post inoculation respectively (Fig 4). Similar 408 
survival rates were also observed when larvae were inoculated with significantly higher 409 
doses of Marinobacter sp. MCTG107b (up to 10,000 CFU in 20 µLμl) (data not shown). 410 
 411 
Discussion 412 
Marine bacteria are reported to secrete surface-active molecules that can interact 413 
with hydrocarbons to increase the emulsification of the hydrocarbon molecules in 414 
seawater to enable these, and also non-biosurfactant producing bacteria to access 415 
these molecules for uptake and use as a source of carbon and energy [39, 40]. 416 
Marinobacter, a genus of Gammaproteobacteria, has previously been shown 417 
capable of utilising hydrocarbons as growth substrates by producing biosurfactants 418 
or bioemulsifier [41, 42]. In the present study, five marine bacterial strains, which 419 
were originally isolated for their ability to grow on and degrade PAHs, were identified 420 
to belong to the genus Marinobacter based on 16S rDNA gene sequencing. These 421 
isolates were screened to evaluate their potential as biosurfactant producers when 422 
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18 
cultivated in marine media using rapeseed oil as a carbon source. Many previous 423 
studies have reported that the inclusion of peptone in marine media is essential for 424 
biosurfactant synthesis [43, 44]. Here we show that in response to adding rapeseed 425 
oil to peptone containing ZM/1 media, these five Marinobacter strains displayed 426 
varying phenotypic responses which were indicative of biosurfactant synthesis. 427 
Phenotypic comparison of all these strains showed that Marinobacter sp. 428 
MCTG107b, isolated from sea surface water samples off the coast of Oregon, USA, 429 
showed maximum reduction in the surface tension of cell-free supernatant fractions. 430 
As the ability to reduce the surface tension of cell-free supernatant is a key 431 
phenotypic marker of low-molecular weight biosurfactant synthesis, this strain was 432 
selected for further investigation [45]. 433 
Considering that subtle changes in salinity and pH can exert an important 434 
effect on microbial communities in the marine environment [46, 47], these 435 
parameters were tested for their influence on the growth of strain MCTG107b and its 436 
production of biosurfactant. Indeed, several studies have shown the effect of these 437 
two parameters on bacterial biosurfactant synthesis. For example, Bacillus subtilis 438 
N3-1P, isolated from brewery waste, reduced the surface tension of the culture 439 
medium to the greatest extent at a pH of 6.41 when compared to a range of other 440 
media pHs [48]. A thermophilic and halo-tolerant strain of P. aeruginosa, isolated 441 
from oil-contaminated soil, produced biosurfactant when cultured in media containing 442 
a salinity range of 0–6% (w/v) [49]. In contrast B. licheniformis BAS50, isolated from 443 
a deep oil well, produced biosurfactant when using a salinity of up to 13% NaCl, 444 
which is a salinity equivalent to that present in many petroleum reservoirs [50]. 445 
Based on these previous studies, we carried out FFD modelling to identify optimal 446 
concentrations of salinity and pH for the maximal production of biosurfactant by 447 
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strain MCTG107b, and which revealed that a pH range of 5.0–6.8 and salinity 448 
concentration of 22.5–40 gL-1 were optimal. Interestingly, while salinity was the 449 
dominant factor affecting the reduction of surface tension, the strain preferred an 450 
acidic pH for increased biosurfactant production. This was at the expense of 451 
bacterial growth, indicating that when the culture medium was alkaline, cells were 452 
directed to the production of cellular biomass over biosurfactant synthesis. Whilst not 453 
within the focus of this study, future work could be directed to explore this pH-454 
mediated biosurfactant response and whether it is transposable to the global ocean 455 
in order to predict microbial biosurfactant production under future climate change 456 
conditions, such as ocean acidification. The profile of a marked fall in surface tension 457 
during the exponential growth phase coupled with a sustained low surface tension 458 
during stationary phase indicated the biosurfactant produced by strain MCTG107b is 459 
likely a secondary metabolite, as has been similarly reported for P. aeruginosa [51], 460 
B. thailendensis [23] and marine Pseudomonas sp. MCTG214(3b1) [20].  461 
Orcinol assay yielded 150 μgmL-1 of rhamnolipid in the cell free supernatant.  462 
Orcinol assay is a colorimetric method for the rapid indication of rhamnolipid in the 463 
fermentation broth. However, the limitation of orcinol method is that, it is not  specific 464 
for rhamnose and impurities present in the sample might interfere with the actual 465 
yield. We followed the criteria suggested by Irorere et al. (2017) to quantify 466 
biosurfactant yield gravimetrically. The final yield of rhamnolipid was 740 ± 28.3 mgL-467 
1 from the SPE purified sample. SPE purification of crude biosurfactant removed 468 
excess lipids from the sample which gave an absolute quantification of rhamnolipid 469 
yield. Similarly, Perfumo et al. (2013) reported purified rhamnolipid yields in the 470 
range of 0.8–1.7 gL-1 from P. aeruginosa strains. While, the orcinol assay provided 471 
an overestimation of rhamnolipids at 7.7–9.5 gL-1.  472 
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The chemical characterisation of the purified biosurfactant synthesised by 473 
strain MCTG107b was achieved using HPLC-MS – a methodology demonstrated to 474 
be the most effective for identifying biosurfactant compounds [35], as described in a 475 
recent review by Irorere et al. (2017). We identified 14 separate rhamnolipid 476 
congeners with Rha-Rha-C10-C10 (m/z 651) being the most abundant (52.45%). 477 
Furthermore, elucidation of this major molecular ion synthesised by Marinobacter sp. 478 
MCTG107b was performed by tandem-MS. When fragmented by MS-MS, the parent 479 
ion showed characteristic fragments at m/z 479 and m/z 339, which were in 480 
agreement with the previous tandem-MS analysis of Rha-Rha-C10-C10 performed by 481 
Zhao et al. [52]. The pattern of rhamnolipid congeners synthesised by this strain was 482 
highly similar to the rhamnolipid congeners that have been shown to be produced by 483 
both P. aeruginosa and marine Pseudomonas sp. MCTG214(3b1), but contrasts with 484 
B. thailandensis which produces an abundance of congeners with di-rhamnolipid 485 
containing C14 [18, 20, 23]. The composition of rhamnolipid congeners greatly affects 486 
its properties. Mono-rhamnolipids have been reported to more effectively solubilise 487 
PAHs compared to di-rhamnolipids. However, di-rhamnolipids have better rate of 488 
biodegradation than mono-rhamnolipids due to the slow release of PAH from the 489 
mono-rhamnolipid micelles [53]. This was seen with methyl esters of di-rhamnolipid 490 
which were reported to be effective in promoting alkane degradation [54]. 491 
Interestingly, non-ionic rhamnolipids or methyl esters of di-rhamnolipid C10-C10 and 492 
novel methyl ester of di-rhamnolipid C10-C12 were also identified in this study. In this 493 
study a mono-rhamnolipid with single 3-hydroxy fatty acid chain Rha-C14:2 (3.18%) 494 
was also detected which was previously reported in rhamnolipid produced by P. 495 
aeruginosa mutant MIG-N146 [55]. Under our experimental conditions, MCTG107b 496 
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was able to produce diverse rhamnolipid congeners with aliphatic chains varying 497 
from C8 to C14 and few congeners with unsaturated bonds.  498 
The biosynthesis of rhamnolipids in P. aeruginosa occurs in three enzymatic 499 
steps. In the first step, rhamnosyltransferase chain A RhlA (encoded by the rhlA 500 
gene), synthesizes a fatty acid dimer molecule from β-hydroxy fatty acid precursors 501 
[56]. The second step, RhlB rhamnosyltransferase chain B (encoded by the rhlB 502 
gene), produces mono-rhamnolipids by covalently bonding the previously 503 
synthesised precursor molecule and dTDP-L-rhamnose [57]. The final step, RhlC 504 
rhamnosyltransferase II (encoded by rhlC gene), utilises mono-rhamnolipids 505 
synthesised by RhlA and RhlB as a substrate, adding a second dTDP-L-rhamnose 506 
moiety to produce di-rhamnolipids [58]. The rhamnolipid congener profile produced 507 
by Marinobacter sp. MCTG107b is predominantly skewed toward the synthesis of di-508 
rhamnolipids, whereas mono-rhamnolipids were only found in much smaller 509 
concentrations. Although a prevalence toward di-rhamnolipid synthesis has been 510 
observed in P. aeruginosa, and to an even greater extent in Burkholderia species, 511 
the abundance of di-rhamnolipid versus mono-rhamnolipid in Marinobacter sp. 512 
MCTG107b was significantly higher than that previously observed with other 513 
rhamnolipid-producing organisms. In P. aeruginosa a single copy of rhlA and rhlB 514 
are located in an operon alongside genes encoding an AHL-mediate quorum sensing 515 
system. The rhlC gene is located approx. 1 Mbp down stream of this operon [51]. A 516 
contrasting arrangement was observed in B. thailandensis which has two identical 517 
and functional operons containing orthologues of each rhamnolipid synthesis gene 518 
(rhlA, rhlB and rhlC), possessing only 40% sequence similarity to those of P. 519 
aeruginosa [23, 59]. Therefore, Burkholderia species can simultaneously express 520 
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rhlB and rhlC favouring the immediate addition of the second rhamnosyl group to the 521 
produced mono-rhamnolipid [59]. 522 
We therefore postulate that a biosynthetic pathway similar to that observed in 523 
Burkholderia might be present here and accounting for the higher ratio of di-524 
rhamnolipid to mono-rhamnolipid congeners. The biosynthetic pathway of 525 
rhamnolipid synthesis by Marinobacter sp. has however presented a paradox. 526 
Although not shown here, we have carried out additional PCR screening for rhlA, 527 
rhlB and rhlC using degenerate primers designed from multiple sequence alignments 528 
of both P. aeruginosa and B. thailandensis sequences. To date, This this approach 529 
has failed to amplify any DNA sequence which could be involved in identify any 530 
rhamnolipid synthesis gene orthologues. Our finding that other similar Marinobacter 531 
strains fail to synthesise rhamnolipids The absence of orthologues to the rhl genes 532 
among non-rhamnolipid producing species suggests that the acquisition of 533 
rhamnolipid biosynthesis genes by Marinobacter sp. MCTG107b may have occurred 534 
rhl genes occurs through lateral gene transfer from an unrelated a rhamnolipid 535 
producing species, as has been observed previously in other rhamnolipid 536 
synthesising bacteria [60]. However, based on the un-relatedness of Marinobacter 537 
sp. MCTG107b to previously reported rhamnolipid producers and the significant 538 
sequence differences between the P. aeruginosa and B. thailandensis synthases, we 539 
conclude that rhamnolipid synthesis in this strain is being catalysed by enzymes with 540 
significantly different peptide sequences to either of these other species. This 541 
sequence difference is also present at the genetic level, accounting for the reasons 542 
why our screening protocol failed [23, 59]. Additionally, the observation of mono-543 
rhamnolipid congeners only possessing a single fatty acid side chain being 544 
synthesised by this strain corroborates this conclusion since RhlA in both P. 545 
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aeruginosa and Burkholderia species utilises fatty acid dimers as a substrate for 546 
rhamnolipid synthesis [56, 59]. To further investigate this the mechanisms of 547 
rhamnolipid biosynthesis, we recently obtained the complete genome sequence of 548 
Marinobacter sp. MCTG107b. We are therefore, currently in the process of carrying 549 
out comparative genomic analysis with various other , we are currently combining 550 
comparative sequence analysis with whole genome sequencing of various 551 
Marinobacter strains, with the aim of identifying to identify putative geneticgene 552 
candidates for rhamnolipid biosynthesis. 553 
 554 
Conclusions 555 
Marinobacter sp. MCTG107b, isolated from the marine environment, has the ability 556 
to synthesise a wide variety of rhamnolipid congeners. To the best of our knowledge, 557 
rhamnolipid production has not been previously observed in any member of the 558 
genus Marinobacter. Therefore, the results presented here expand the list of known 559 
rhamnolipid producing bacterial taxa to include Marinobacter; a genus of marine 560 
bacteria that shows little to no association with human pathogenicity. Although the 561 
major hurdle of low production yield remains, synthesis of rhamnolipids from novel, 562 
non-pathogenic marine species, such as Marinobacter sp. MCTG107b, is promising 563 
for the scale-up in bioprocessing industry or to provide genetic resources for 564 
metabolic engineering for the production of specific rhamnolipid congeners. 565 
 566 
Additional file 1. Fig. S1. Effect of various sea salt concentrations, pH, temperature 567 
and nitrogen source on the growth of Marinobacter sp. MCTG107b over a period of 568 
96h. Growth curves show the OD600 of strain MCTG107b during growth at different (A) 569 
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salinities (5.0 to 40 g/L-1), (B) pH values (4.0 to 8.5), or (C) temperatures (25 °CoC, 28 570 
°CoC, 30 °CoC, 37 °CoC). 571 
Fig. S2. HPLC-MS chromatogram for rhamnolipids produced by Marinobacter sp. 572 
MCTG107b. The MS was operated in the negative mode. Main intensities in the 573 
chromatogram were Rha-Rha-C10-C10 and Rha-Rha-C10-C10-CH3. 574 
Table S1. Full 22 factorial design with pH and salt as independent variables using 575 
surface tension and biosurfactant yield as response variables.  Surface tension and 576 
biosurfactant yield according to full factorial design after 96 h of shake-flask study of 577 
Marinobacter sp. MCTG107b. 578 
Table S2. Analysis of variance (ANOVA) for response variables surface tension and 579 
biosurfactant yield by Marinobacter sp. MCTG107b 580 
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Tables 862 
TABLE 1. Phylogenetic identification and biosurfactant phenotypic screening results for each bacterial strain. Bacteria were identified 863 
by 16S rDNA gene sequencing. Surface tension values (mNm-1) and EI24 (%) were obtained from cell-free supernatant samples of 864 
cultures incubated for 96 h. * ST and † EI 24 h of sterile ZM/1 medium was 58 mNm-1 and 0%, respectively. 865 
Strain Origin BLASTn Identification 
(Against NCBI database) 
GeneBank 
Accession Number  
Sequence 
Similarity Phenotypic Screening 
  ST (mNm-1) * EI 24 h (%) † 
MCTG106 
Coastal surface water, 
Oregon, Washington 
State, USA 
Marinobacter sp. 
NP1383C-30R 
MK894600 100% 54.63 ±3.5 40 ± 1.5 
MCTG4b 
Laboratory culture of 
Thalassiosira weissflogii 
strain CCMP 1052 
isolated from Oslo Fjord, 
Norway 
Marinobacter sp. Set72 MK894835 99% 38.5 ± 0.6 42 ± 2.0 
MCTG167 
Phytoplankton net tow, 
Oban, UK 
Marinobacter sp. T23 MK894854 100% 61.55 ± 0.1 N/A 
MCTG161(2c3) 
Phytoplankton net tow, 
Oban, UK 
Marinobacter adhaerens 
HP15 
MK894872 99% 60.0 ± 0.5 45 ± 2.0 
MCTG107b 
Coastal surface water, 
Oregon, Washington 
State, USA Marinobacter sp. R-28768 MK578516 100% 31.0 ± 0.5 40 ± 1.8 
866 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
32 
TABLE 2. Composition of rhamnolipid congeners synthesised by Marinobacter sp. 867 
MCTG107b. Rhamnolipid congeners were identified via HPLC-MS in SPE purified 868 
extracts from cell-free culture supernatant samples obtained after 96 h growth in a 869 
bioreactor. 870 
RT 
min 
m/z 
value 
Compound Mw 
(Da) 
Molecular 
Form 
Relative 
% 
Mono-rhamnolipid congeners 
14.8 387.22 Rha-C14:2 386.48 C20H34O7 3.18 
21.5 533.46 Rha-C10-C12 / Rha-C12-C10 532.71 C28H52O9 0.22 
24.2 503.47 Rha-C10-C10:1 502.64 C26H46O9 0.27 
26.9 561.52 Rha-C12-C12/ Rha-C10-C14 560.76 C30H56O9 0.94 
Subtotal 4.61 
Di-rhamnolipid congeners 
4.6 453.27 Rha-Rha-C8 452.49 C20H36O11 1.95 
12.7 480.39 Rha-Rha-C10 480.55 C22H40O11 5.13 
22.1 537.45 Rha-Rha-C14 536.65 C26H48O11 0.21 
31.0 649.71 Rha-Rha-C10-C10:1 / Rha-Rha-C10:1-C10 648.74 C32H56O13 2.85 
32.1 651.73 Rha-Rha-C10-C10 650.79 C34H58O13 52.45 
32.8 677.77 Rha-Rha-C10-C12:1 676.83 C33H60O13 1.06 
33.0 665.77 Rha-Rha-C10-C10-CH3 664.82 C42H60O13 23.07 
34.5 803.54 Decenoyl-Rha-Rha-C10-C10:1 801.01 C35H72O11 0.40 
35.1 679.78 Rha-Rha-C10-C12 / Rha-Rha-C12-C10 678.84 C35H64O13 5.01 
37.2 693.90 Rha-Rha-C10-C12-CH3 / Rha-Rha-C12-C10-CH3 692.80 C35H64O13 3.26 
Subtotal 95.39 
 871 
Figure Legends 872 
 873 
Fig 1. Three-dimensional response surface plot modelling the effect of varying media 874 
pH and salt concentration on (A) biosurfactant yield and (B) cell-free supernatant 875 
surface tension. The different coloured areas of these plots represent various bands 876 
for either predicated yield or predicted surface tension. The values of each band are 877 
provided in the key next to each panel.   878 
 879 
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Fig 2. Biomass and surface tension reduction kinetics of Marinobacter sp. MCTG107b 880 
during growth under optimised conditions using 1% (v/v) rapeseed oil as a carbon 881 
source in a 5L bioreactor. Surface tension () was seen to reduce to a stable value 882 
within the first 24 h of growth and corresponded with the strain reaching the stationary 883 
growth phase, as measured by viable cell counts ().   884 
 885 
Fig 3. HPLC-MS-MS profile of daughter products resulting from the fragmentation of 886 
a molecular ion with an m/z of 651.73, observed in a previous HPLC-MS analysis to 887 
be the predominant compound in supernatant extracts from Marinobacter sp. 888 
MCTG107b. The observed products corresponded to the predicted molecular weights 889 
of the fragmentation of di-rhamnolipid Rha-Rha-C10-C10. Fragments below m/z 205 890 
were not detected due to sensitivity of the instrument. 891 
 892 
Fig 4. Kaplan-Meier plot showing percentage survival of Galleria mellonella larvae 893 
after inoculation with either Marinobacter sp. MCTG107b or P. aeruginosa PAO1. 894 
Within a 48 h incubation there was no significant mortality observed after infection with 895 
cells of strain MCTG107b as opposed to infection with strain PAO1 where 100% 896 
mortality was observed following 24 h incubation. Additionally, no significant mortality 897 
was observed in larvae inoculated with the carrier control buffer (PBS). n = 30 (pooled 898 
from 3 X duplicate experiments).  899 
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